3

MAIN DOCUMENT DESCRIPTION

Company: Jazz Pharmaceuticals plc
Filed: May 31, 2007
Period of Report: May 31, 2007
Accession Number: 0001209191-07-034029

View Document ↗ View on SEC.gov ↗